Abstract:Objective:To compare the efficacy and safety of risperidone and chlorpromazine in treatment of first-episode schizo phrenia.Methods:It is a one year naturalistic study.One hundred and eighty-six patients with first-episode of schizophrenia were included who met ICD-10 criteria for schizophrenia or schizophreniform disorder and received integrated treatment(risper- idone or chlorpromazine plus psychosocial education,family psycho-education).There were 131 patients included in the risperi- done group and 55 included in the chlorpromazine group.Written informed consent was obtained from the patients or their legal guardians.Clinical stains was assessed with the Positive and Negative Symptom Scale(PANSS).the Treatment Emergent Symptom Scale(TESS)and the time to the discontinuation of treatment.The Short Form-36(sf-36)was used to assess the quality of life.Results:Thirty-five percent in the rieperdone group partially completed follow-up assessments and 51% in the chlor promazine group did.the difference of the rates between the two groups was significant.Response rate was defined as improvement in PANSS total score of≥50%.The response rates at the end of 2.3.6.8.12 months in the risperidone group were 29.1%.41.8%. 50.9%.50.9%.56.4% and in the chlorpromazine group were 40.5%.46.6%.57.3%.64.1%.62.6%.respectively.There was no significant difference of the response rate at any of the follow up time between the two groups.The relapse rates were similar as 20. 2% in the risperidone group and 20.6% in the comparing group.The time to the discontinuation of treatment for any cause was longer in the risperidone group than in the chlorpromazine gronp.However.the difference was not significant.Risperidone was associated with lower symptoms of tremor,constipation,sialorrhea(P0.01)and also associated with more frequent reports of agitation,de- pression,insomnia,gastrointestinal disturbance,menstrual disorder(P0.05).There are significant improvements in 6 factors (role of physics,body pain.globe health,social function,role of emotion and mental heahh)of sf 36 in risperidone group and only 2 factory(social function,role of emotion)in the comparative group.Conclusion:The efficacy of risperidone is as same as that of chlorpromazine in the treatment of first-episode schizophrenia,yet the rates of some adverse events are different in the two groups and risperidone may enhance the quality of life from more aspects.

Adjunctive Celecoxib Treatment with Risperidone in First-Episode Schizophrenia: a Double Blind,randomized and Placebo Controlled Trial

Effects of Adjunctive Celecoxib Treatment with Risperidone on the Cognitive Function in First-Episode Schizophrenia Patients

A double blinded multicenter clinical trial for evaluating the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia

Efficacy and Safety of Long-Acting Risperidone on Early Onset Schizophrenia in Adolescent Patients

Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial

Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia

Double-blind,double-dummy and randomized controlled study of aripiprazole in the treatment of acute schizophrenia

Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-Analysis of 11 Randomized Clinical Trials

A Randomized,open Label and Parallel-Control Study for the Treatment of Refractory Schizophrenia with Risperidone and Clozapine

Risperidone Versus Haloperidol in the Treatment of Acute Exacerbations of Chronic Inpatients with Schizophrenia: a Randomized Double-Blind Study

Efficacy and Safety of Aripiprazole in the Treatment of Schizophrenia: a Randomized, Double-Blind, Risperidone Controlled, Multicenter Study

Therapeutic Effects of Cerebrolysin Added to Risperidone in Patients with Schizophrenia Dominated by Negative Symptoms

Aripiprazole and risperidone in treatment of the patients with schizophrenia: a randomly clinical trial

Double-blind Comparison of Ziprasidone and Risperidone in the Treatment of Chinese Patients with Acute Exacerbation of Schizophrenia

Clinical Study of Risperidone Orally Disintegrating Tabiets and Clozapine in the Treatment of Schizophrenia

A Multicenter Study of Risperidone Treatment for Acute Agitation in Patients with Schizophrenia

Repetitive Transcranial Magnetic Stimulation In Combination With Citalopram In Young Patients With First-Episode Major Depressive Disorder: A Double-Blind, Randomized, Sham-Controlled Trial

Quetiapine and risperdal in the treatment of schizophrenia:an one-year follow up study.

One Year Follow-up Study: Risperidone and Chlorpromazine for Patients with First-episode Schizophrenia

Study on Efficacy and Safety of Risperidone in Treatment of Different Kinds of Schizophrenia

PIH21 EFFICACY AND SAFETY OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN PATIENTS WITH OSTEOARTHRITIS: A NETWORK META-ANALYSIS